1. EachPod

JAMA Neurology : High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

Author
American Medical Association, 2017
Published
Mon 25 Mar 2024
Episode Link
https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamaneurol.2024.838

Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD.

Related Content:

Share to: